HomeVTYX • NASDAQ
add
Ventyx Biosciences Inc
Previous close
$8.00
Day range
$7.84 - $9.00
Year range
$0.78 - $10.55
Market cap
622.25M USD
Avg Volume
6.82M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.87M | -35.48% |
Net income | -22.83M | 35.24% |
Net profit margin | — | — |
Earnings per share | -0.32 | 36.00% |
EBITDA | -24.82M | 35.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 192.64M | -29.91% |
Total assets | 211.46M | -29.77% |
Total liabilities | 20.10M | -9.97% |
Total equity | 191.36M | — |
Shares outstanding | 71.36M | — |
Price to book | 2.99 | — |
Return on assets | -28.17% | — |
Return on capital | -29.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -22.83M | 35.24% |
Cash from operations | -17.51M | 50.63% |
Cash from investing | 17.05M | -41.70% |
Cash from financing | 203.00K | -99.24% |
Net change in cash | -331.00K | -101.59% |
Free cash flow | -9.02M | 57.60% |
About
Founded
2018
Website
Employees
83